Dexatrenz Pharmaceutical Private Limited
About Dexatrenz Pharmaceutical Private Limited
Data last updated:
Dexatrenz Pharmaceutical Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U74993JH2018PTC011004.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sumit Kumar Singh and Nilu Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/O Ramjee Singh Lower Karam Toli Ps: Lalpur Po: Morabadi, Ranchi, Jharkhand, India – 834008.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.88 Lakh, a decline of 56% compared to the previous year. For the same year it recorded a net profit of ₹2,969 (net margin 0.5%) and EBITDA of ₹4,012 (EBITDA margin 0.7%).
Company details
Contact details
Dexatrenz Pharmaceutical Private Limited's registered office is in Ranchi, Jharkhand.
- Registered AddressH/O Ramjee Singh Lower Karam Toli Ps: Lalpur Po: Morabadi, Ranchi, Jharkhand, India – 834008
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dexatrenz Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dexatrenz Pharmaceutical Private Limited, buy the company report.
Financials of Dexatrenz Pharmaceutical Private Limited
FY 2025 filings availableDexatrenz Pharmaceutical Private Limited reported revenue of ₹5.88 Lakh (down 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 56% in the latest year. EBITDA fell 50% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,012 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,969 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dexatrenz Pharmaceutical Private Limited, buy the company report.
Board of directors of Dexatrenz Pharmaceutical Private Limited
Dexatrenz Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Kumar Singh | Director | 28 Jun 2024 | 2 Years 4 Months | Current |
| Nilu Devi | Director | 20 Feb 2018 | 8 Years 8 Months | Current |
Peer comparison
Dexatrenz Pharmaceutical Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Exotic Flavors Online Private Limited | ₹5.88 Lakh (FY 2016) | Navi Mumbai, Maharashtra, India | ||||
| Ytmoon Refrigeration Private Limited | ₹5.88 Lakh (FY 2023) | 650.0% | Mumbai, Maharashtra, India | |||
| Zishah Shawls Private Limited | ₹5.88 Lakh (FY 2022) | Delhi, India | ||||
| Bromas Livestock Private Limited | ₹5.88 Lakh (FY 2022) | Namakkal, Tamil Nadu, India | ||||
| Fipras International Private Limited | ₹5.88 Lakh (FY 2025) | -9.0% | Mmc, Tamil Nadu, India | |||
| Dexatrenz Pharmaceutical Private Limitedthis company | ₹5.88 Lakh (FY 2025) | ₹2,969 | 0.5% | -56.0% | Ranchi, Jharkhand, India | |
| MRSR Sports Private Limited | ₹5.88 Lakh (FY 2025) | 359.0% | Ambala, Haryana, India | |||
| Mahavir Textures and Powerlooms Private Limited | ₹5.88 Lakh (FY 2016) | 29.0% | Navapur, Maharashtra, India | |||
| Wellness and Hygiene 4U Private Limited | ₹5.88 Lakh (FY 2025) | 56.0% | New Delhi, Delhi, India | |||
| Zak Global Trading Private Limited | ₹5.88 Lakh (FY 2024) | -78.0% | Tiruchirappalli, Tamil Nadu, India |
To see the full peer comparison of Dexatrenz Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dexatrenz Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dexatrenz Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dexatrenz Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dexatrenz Pharmaceutical Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Rupika Kumari ceased to be Director on 04 Jul 2024.
Frequently asked questions
Dexatrenz Pharmaceutical is an active private limited company based in Ranchi, Jharkhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 February 2018 (8+ years old) and is registered under CIN U74993JH2018PTC011004.
Dexatrenz Pharmaceutical has 2 current directors:
- Sumit Kumar Singh - Director
- Nilu Devi - Director
The latest financial statements of Dexatrenz Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Dexatrenz Pharmaceutical is U74993JH2018PTC011004. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dexatrenz Pharmaceutical was incorporated on 20 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Dexatrenz Pharmaceutical by revenue are Exotic Flavors Online Private Limited, Ytmoon Refrigeration Private Limited, Zishah Shawls Private Limited, Bromas Livestock Private Limited, Fipras International Private Limited and 4 more, all in the same principal business activity (wholesale trading).
Rupika Kumari ceased to be Director on 04 Jul 2024. Sumit Kumar Singh was appointed as Director on 28 Jun 2024. Ridhi Deepa Das ceased to be Director on 06 Sep 2018. Dexatrenz Pharmaceutical has 4 board changes on record in total.
The registered office of Dexatrenz Pharmaceutical is at HO Ramjee Singh Lower Karam Toli Ps: Lalpur Po: Morabadi, Ranchi, Jharkhand, India – 834008.
Dexatrenz Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Dexatrenz Pharmaceutical can be reached at its registered office: HO Ramjee Singh Lower Karam Toli Ps: Lalpur Po: Morabadi, Ranchi, Jharkhand, India – 834008.
Dexatrenz Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Ranchi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
